CytomX Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $71.1M | $197.2M | $59.8M |
| FY2016 | $120.6M | $199.1M | $104.6M |
| FY2017 | $327.7M | $397.6M | $177.5M |
| FY2018 | $326.2M | $457.1M | $247.6M |
| FY2019 | $290.2M | $341.3M | $188.4M |
| FY2020 | $366.4M | $358.7M | $191.9M |
| FY2021 | $353.5M | $339.4M | $205.5M |
| FY2022 | $326.6M | $260.9M | $193.7M |
| FY2023 | $249.2M | $201.8M | $17.2M |
| FY2024 | $121.0M | $120.5M | $38.1M |